092730.KQ
NeoPharm Co. Ltd.
KOE · Consumer Defensive · Household & Personal Products · KR
KRW 23,150.00
−2.94%Year over year
Reported trailing growth
- Revenue
- +19.9%
- EBITDA
- +24.6%
- EBIT
- +22.3%
- EPS
- +20.5%
- Free cash flow
- +11.0%
- Operating cash flow
- +8.8%
Forward estimates
Based on analyst estimates
- Revenue
- -40.9%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +15.8%
- EBITDA
- +8.6%
- EBIT
- +10.3%
- Net income
- +17.9%
- EPS
- +17.8%
- Free cash flow
- +16.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026